BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19456779)

  • 1. Improvement in docetaxel-induced nail changes associated with cyclooxygenase-2 inhibitor treatment.
    Nakamura S; Kajita S; Takagi A; Hashimoto Y; Ishida-Yamamoto A; Takahashi H; Iizuka H
    Clin Exp Dermatol; 2009 Oct; 34(7):e320-1. PubMed ID: 19456779
    [No Abstract]   [Full Text] [Related]  

  • 2. Taxan-associated nail toxicity.
    Doleschal B; Petzer A; Aichberger KJ
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28143862
    [No Abstract]   [Full Text] [Related]  

  • 3. Regression of hepatocellular carcinoma due to cyclooxygenase (COX)-2 inhibitor.
    Dohmen K; Okabe H; Ishibashi H
    Am J Gastroenterol; 2006 Oct; 101(10):2437-8. PubMed ID: 17032211
    [No Abstract]   [Full Text] [Related]  

  • 4. [Onycholysis due to docetaxel in breast cancer treatment].
    Grasland A; Grandjean M; Rist S; Bosquet A; Vinceneux P
    Rev Med Interne; 2005 May; 26(5):427-8. PubMed ID: 15893036
    [No Abstract]   [Full Text] [Related]  

  • 5. Docetaxel-induced onycholysis: the role of subungual hemorrhage and suppuration.
    Roh MR; Cho JY; Lew W
    Yonsei Med J; 2007 Feb; 48(1):124-6. PubMed ID: 17326255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical picture: nail changes secondary to docetaxel.
    Wasner G; Hilpert F; Baron R; Pfisterer J
    Lancet; 2001 Mar; 357(9260):910. PubMed ID: 11289346
    [No Abstract]   [Full Text] [Related]  

  • 7. Trastuzumab/docetaxel-induced nail dystrophy.
    Alexandrescu DT; Vaillant J; Wiernik PH
    Int J Dermatol; 2006 Nov; 45(11):1334-6. PubMed ID: 17076719
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe nail changes due to Docetaxel treatment.
    Rafi L; Friedrich M; Tilgen W; Reichrath J
    Eur J Dermatol; 2003; 13(6):610-1. PubMed ID: 14721789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel-induced onycholysis.
    Prabhash K; Babu KG; Ravi S; Girish MH; Bapsy PP
    J Assoc Physicians India; 2004 Feb; 52():167-8. PubMed ID: 15656060
    [No Abstract]   [Full Text] [Related]  

  • 10. Subungueal pyogenic granuloma secondary to docetaxel therapy.
    Devillers C; Vanhooteghem O; Henrijean A; Ramaut M; de la Brassinne M
    Clin Exp Dermatol; 2009 Mar; 34(2):251-2. PubMed ID: 19120399
    [No Abstract]   [Full Text] [Related]  

  • 11. A rare manifestation of nail changes with docetaxel therapy.
    Halvorson CR; Erickson CL; Gaspari AA
    Skinmed; 2010; 8(3):179-80. PubMed ID: 21137627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Examination about the influence for daily life that nail and skin disorders induced by docetaxel in patients with breast cancer].
    Kohama K; Masuda N; Yamamura J; Ishitobi M; Masuda H; Ogawa M; Todaka K; Tanaka T; Ueno H; Nakamori S; Tsujinaka T
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):615-8. PubMed ID: 19381034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subungueal haemorrhages following docetaxel (taxotere) treatment.
    Fenniche S; Hammami H; Badri T; Mokhtar I; Benmously R
    Curr Drug Saf; 2012 Jul; 7(3):247-9. PubMed ID: 22950986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients.
    Ishiguro H; Takashima S; Yoshimura K; Yano I; Yamamoto T; Niimi M; Yamashiro H; Ueno T; Takeuchi M; Sugie T; Yanagihara K; Toi M; Fukushima M
    Support Care Cancer; 2012 Sep; 20(9):2017-24. PubMed ID: 22086405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of feline mammary tumours using chemotherapy, surgery and a COX-2 inhibitor drug (meloxicam): a retrospective study of 23 cases (2002-2007)*.
    Borrego JF; Cartagena JC; Engel J
    Vet Comp Oncol; 2009 Dec; 7(4):213-21. PubMed ID: 19891691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity.
    Can G; Aydiner A; Cavdar I
    Eur J Oncol Nurs; 2012 Jul; 16(3):270-5. PubMed ID: 21784705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mees lines and Beau lines after chemotherapy.
    Huang TC; Chao TY
    CMAJ; 2010 Feb; 182(3):E149. PubMed ID: 20008502
    [No Abstract]   [Full Text] [Related]  

  • 18. Docetaxel chemotherapy induces transverse superficial loss of the nail plate.
    Llombart-Cussac A; Pivot X; Spielmann M
    Arch Dermatol; 1997 Nov; 133(11):1466-7. PubMed ID: 9371043
    [No Abstract]   [Full Text] [Related]  

  • 19. The risk of nail changes with taxane chemotherapy: a systematic review of the literature and meta-analysis.
    Capriotti K; Capriotti JA; Lessin S; Wu S; Goldfarb S; Belum VR; Lacouture ME
    Br J Dermatol; 2015 Sep; 173(3):842-5. PubMed ID: 25704465
    [No Abstract]   [Full Text] [Related]  

  • 20. [Selective cyclooxygenase-2 inhibitor].
    Hettich M; Thomae K
    Internist (Berl); 1997 Oct; 38(10):1007. PubMed ID: 9432492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.